Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study - Concepedia

Concepedia

Publication | Closed Access

Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study

53

Citations

30

References

2008

Year

Duma Khutsoane, Surendra Kumar Sharma, Majeed Almustafa, Hak Chul Jang, Sami T. Azar, R. Danciulescu, Nasrat Ayad, S. Güler, Ole Molskov Bech

Diabetes Obesity and Metabolism

Abstract

The use of BIAsp 30 monotherapy or in combination with OADs in clinical practice was effective and safe in patients with poorly controlled type 2 diabetes mellitus.

References

	Year	Citations

Page 1